Author:
Balerio Graciela N.,Aso Ester,Maldonado Rafael
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Acquas E, Pisanu A, Marrocu P, Di Chiara G (2000) Cannabinoid CB(1) receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo. Eur J Pharmacol 401:179–185
2. Anthenelli RM, Despres JP (2004) Effects of rimonabant in the reduction of major cardiovascular risk factors. Results from the STRATUS-US trial (smoking cessation in smokers motivated to quit). In: American College of Cardiology 53rd annual scientific session, New Orleans, LA, 7–10 Mar 2004
3. Balerio GN, Aso E, Berrendero F, Murtra P, Maldonado R (2004) Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice. Eur J Neurosci 20:2737–2748
4. Balerio GN, Aso E, Maldonado R (2005) Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology 181:260–269
5. Brazell MP, Mitchell SN, Gray JA (1991) Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: a dose–response and antagonist study. Neuropharmacology 30:823–833